Literature DB >> 18651839

Transcriptional regulation of the TGF-beta1 promoter by androgen receptor.

Wei Qi1, Shen Gao, Zhengxin Wang.   

Abstract

TGF (transforming growth factor)-beta1 is a multifunctional cytokine that influences homoeostatic processes of various tissues. TGF-beta1 expression is inhibited by androgens in the prostate gland, whereas its expression is enhanced by androgens in highly metastatic prostate cancer cells. Here, we examined regulation of human TGF-beta1 promoter activity by androgen in prostate cancer cells. The full-length (-3363 to +110) promoter showed a high level of activity in response to androgen in PC3mm2 cells expressing AR (androgen receptor). Further deletion analysis revealed three distal and three proximal AREs (androgen-response elements) in the promoter. Gel-shift and footprint assays show that these AREs physically interact with the DNA-binding domain of AR. Chromatin immunoprecipitation assays revealed the androgen-dependent recruitment of AR to the ARE-containing regions of the TGF-beta1 gene. More importantly, a negative ARE was detected in the TGF-beta1 promoter. Both positive and negative AREs are functional in the androgen-regulated transcription of the TGF-beta1 promoter. These findings imply that androgen signalling may positively or negatively regulate TGF-beta1 expression in response to various signals or under different environmental conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651839     DOI: 10.1042/BJ20080651

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.

Authors:  Lance D Presser; Steven McRae; Gulam Waris
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 2.  The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs.

Authors:  Ulrich H Weidle; Alexandra Epp; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2019 Jan-Feb       Impact factor: 4.069

3.  DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; Bingcheng Wang; Thomas J Kelley; David Danielpour
Journal:  Mol Endocrinol       Date:  2010-08-25

4.  Endocrine disruption of brain sexual differentiation by developmental PCB exposure.

Authors:  Sarah M Dickerson; Stephanie L Cunningham; Heather B Patisaul; Michael J Woller; Andrea C Gore
Journal:  Endocrinology       Date:  2010-12-29       Impact factor: 4.736

5.  The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study.

Authors:  Tamra E Meyer; Lisa W Chu; Qizhai Li; Kai Yu; Philip S Rosenberg; Idan Menashe; Anand P Chokkalingam; Sabah M Quraishi; Wen-Yi Huang; Jocelyn M Weiss; Rudolf Kaaks; Richard B Hayes; Stephen J Chanock; Ann W Hsing
Journal:  Prostate       Date:  2011-04-25       Impact factor: 4.104

6.  Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.

Authors:  Tzu-Hua Lin; Soo Ok Lee; Yuanjie Niu; Defeng Xu; Liang Liang; Lei Li; Shauh-Der Yeh; Naohiro Fujimoto; Shuyuan Yeh; Chawnshang Chang
Journal:  J Biol Chem       Date:  2013-05-16       Impact factor: 5.157

7.  Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.

Authors:  Hong Pu; Joanne Collazo; Elisabeth Jones; Dustin Gayheart; Shinichi Sakamoto; Adam Vogt; Bonnie Mitchell; Natasha Kyprianou
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

Review 8.  miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.

Authors:  Sundas Fayyaz; Ammad Ahmad Farooqi
Journal:  Immunogenetics       Date:  2013-04-05       Impact factor: 2.846

Review 9.  Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.

Authors:  T Karantanos; P G Corn; T C Thompson
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

10.  Sexually Dimorphic Crosstalk at the Maternal-Fetal Interface.

Authors:  Tianyanxin Sun; Tania L Gonzalez; Nan Deng; Rosemarie DiPentino; Ekaterina L Clark; Bora Lee; Jie Tang; Yizhou Wang; Barry R Stripp; Changfu Yao; Hsian-Rong Tseng; S Ananth Karumanchi; Alexander F Koeppel; Stephen D Turner; Charles R Farber; Stephen S Rich; Erica T Wang; John Williams; Margareta D Pisarska
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.